Cargando…

Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up

Photodynamic therapy (PDT) treatment for multiple actinic keratosis (AK) has been found effective when lower doses of red light were used with methyl aminolaevulinic acid (MAL). The aim of this study was to compare the results of lower doses of red light conventional PDT (h-PDT, 16 J/cm(2)) with MAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández Guarino, Montserrat, Fernández-Nieto, Diego, Montes, Laura Vila, Lobo, Dario de Perosanz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775939/
https://www.ncbi.nlm.nih.gov/pubmed/36551974
http://dx.doi.org/10.3390/biomedicines10123218
_version_ 1784855755584700416
author Fernández Guarino, Montserrat
Fernández-Nieto, Diego
Montes, Laura Vila
Lobo, Dario de Perosanz
author_facet Fernández Guarino, Montserrat
Fernández-Nieto, Diego
Montes, Laura Vila
Lobo, Dario de Perosanz
author_sort Fernández Guarino, Montserrat
collection PubMed
description Photodynamic therapy (PDT) treatment for multiple actinic keratosis (AK) has been found effective when lower doses of red light were used with methyl aminolaevulinic acid (MAL). The aim of this study was to compare the results of lower doses of red light conventional PDT (h-PDT, 16 J/cm(2)) with MAL and aminolaevulinic acid (ALA) in a long-term follow-up. Patients with more than five symmetrical AK on the scalp who were candidates for PDT were selected and divided randomly between MAL and ALA treatment and patients were followed at 3 and 12 months. The responses were assessed by counting the total AK and the AK per patient. Pain and adverse events were also compiled. A total of 46 patients were treated, 24 with MAL, and 22 with ALA. The two groups were comparable at baseline (p > 0.005). No significant differences were found in the results of both treatments at 12 months, despite ALA exhibiting slightly better results at 3 months. No differences in pain and adverse events were assessed. Both ALA and MAL were effective when lower doses of red light were used in c-PDT. Long term efficacy was also documented. Further studies are necessary to determine the inferior point of red-light illumination without losing efficacy.
format Online
Article
Text
id pubmed-9775939
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97759392022-12-23 Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up Fernández Guarino, Montserrat Fernández-Nieto, Diego Montes, Laura Vila Lobo, Dario de Perosanz Biomedicines Brief Report Photodynamic therapy (PDT) treatment for multiple actinic keratosis (AK) has been found effective when lower doses of red light were used with methyl aminolaevulinic acid (MAL). The aim of this study was to compare the results of lower doses of red light conventional PDT (h-PDT, 16 J/cm(2)) with MAL and aminolaevulinic acid (ALA) in a long-term follow-up. Patients with more than five symmetrical AK on the scalp who were candidates for PDT were selected and divided randomly between MAL and ALA treatment and patients were followed at 3 and 12 months. The responses were assessed by counting the total AK and the AK per patient. Pain and adverse events were also compiled. A total of 46 patients were treated, 24 with MAL, and 22 with ALA. The two groups were comparable at baseline (p > 0.005). No significant differences were found in the results of both treatments at 12 months, despite ALA exhibiting slightly better results at 3 months. No differences in pain and adverse events were assessed. Both ALA and MAL were effective when lower doses of red light were used in c-PDT. Long term efficacy was also documented. Further studies are necessary to determine the inferior point of red-light illumination without losing efficacy. MDPI 2022-12-12 /pmc/articles/PMC9775939/ /pubmed/36551974 http://dx.doi.org/10.3390/biomedicines10123218 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Fernández Guarino, Montserrat
Fernández-Nieto, Diego
Montes, Laura Vila
Lobo, Dario de Perosanz
Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
title Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
title_full Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
title_fullStr Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
title_full_unstemmed Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
title_short Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
title_sort methyl aminolaevulinic acid versus aminolaevulinic acid photodynamic therapy of actinic keratosis with low doses of red-light led illumination: results of long-term follow-up
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775939/
https://www.ncbi.nlm.nih.gov/pubmed/36551974
http://dx.doi.org/10.3390/biomedicines10123218
work_keys_str_mv AT fernandezguarinomontserrat methylaminolaevulinicacidversusaminolaevulinicacidphotodynamictherapyofactinickeratosiswithlowdosesofredlightledilluminationresultsoflongtermfollowup
AT fernandeznietodiego methylaminolaevulinicacidversusaminolaevulinicacidphotodynamictherapyofactinickeratosiswithlowdosesofredlightledilluminationresultsoflongtermfollowup
AT monteslauravila methylaminolaevulinicacidversusaminolaevulinicacidphotodynamictherapyofactinickeratosiswithlowdosesofredlightledilluminationresultsoflongtermfollowup
AT lobodariodeperosanz methylaminolaevulinicacidversusaminolaevulinicacidphotodynamictherapyofactinickeratosiswithlowdosesofredlightledilluminationresultsoflongtermfollowup